This inventor holds 1 USPTO granted patent. Top assignee: Polymun Scientific Immunbiologische Forschung Gmbh. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Regina Voglauer: Innovator in Influenza Research
Introduction
Regina Voglauer is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of virology, particularly in the development of recombinant influenza A viruses. Her innovative work has implications for vaccine development and understanding viral mechanisms.
Latest Patents
Regina Voglauer holds a patent related to recombinant influenza A viruses. The invention pertains to a recombinant NS gene of an influenza A virus that includes a functional RNA binding domain and a gene sequence modification after nucleotide position 400 of the NS1 gene segment. This modification inhibits the transcription of the remaining portion of the NS1 gene segment. The patent also covers various embodiments, including modifications that consist of deletions, insertions, or shifts of the open reading frame. Notably, it includes constructs with an insertion of an autocleavage site 2A, the nef gene from HIV-1, or the sequence encoding the ELDKWA-epitope of gp41 of HIV-1. Furthermore, the invention relates to influenza virus transfectants containing the modified NS gene, which exhibit an IFN inducing phenotype, and may or may not be sensitive to IFN. Additionally, it encompasses vaccines that utilize such a chimeric virus.
Career Highlights
Regina Voglauer is associated with Polymun Scientific Immunbiologische Forschung GmbH, where she continues her research and development efforts. Her work has positioned her as a key figure in the field of immunobiological research, particularly in the context of influenza viruses.
Collaborations
Regina collaborates with notable colleagues, including Boris Ferko and Andre Egorov. These partnerships enhance her research capabilities and contribute to the advancement of innovative solutions in virology.
Conclusion
Regina Voglauer's contributions to the field of influenza research through her patent and collaborative efforts highlight her role as an influential inventor. Her work not only advances scientific understanding but also has the potential to impact public health through vaccine development.